The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Aker Christopher Ray since year 2005.
The trader's CIK number is 1762611.
At the time of the last reporting, Aker Christopher Ray was the Sr. VP & General Counsel of Regulus Therapeutics Inc. .
(stock ticker symbol RGLS).
See this page for all insider trading activities at Regulus Therapeutics Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2020-01-02||RGLS||Regulus Therapeutics Inc.||Sale||2,239||.97||2,165|
|2019-11-14||RGLS||Regulus Therapeutics Inc.||Sale||833||.64||533|
|2019-10-01||RGLS||Regulus Therapeutics Inc.||Sale||2,346||.68||1,602|
|2019-08-15||RGLS||Regulus Therapeutics Inc.||Sale||899||.55||495|
|2019-07-01||RGLS||Regulus Therapeutics Inc.||Sale||2,225||1.31||2,919|
|2019-05-15||RGLS||Regulus Therapeutics Inc.||Sale||6,950||1.41||9,799|
|2019-04-01||RGLS||Regulus Therapeutics Inc.||Sale||2,710||.98||2,658|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Aker Christopher Ray (Sr. VP & General Counsel of Regulus Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.